William Blair & Company’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.38M Sell
86,027
-32,855
-28% -$526K ﹤0.01% 807
2025
Q1
$2.31M Sell
118,882
-24,594
-17% -$478K 0.01% 680
2024
Q4
$3.16M Buy
143,476
+19,433
+16% +$428K 0.01% 609
2024
Q3
$2.09M Buy
124,043
+84,605
+215% +$1.42M 0.01% 699
2024
Q2
$471K Sell
39,438
-572
-1% -$6.84K ﹤0.01% 1113
2024
Q1
$443K Sell
40,010
-413,139
-91% -$4.58M ﹤0.01% 1113
2023
Q4
$3.92M Sell
453,149
-3,253
-0.7% -$28.2K 0.01% 518
2023
Q3
$3.49M Sell
456,402
-16,461
-3% -$126K 0.01% 515
2023
Q2
$3.4M Sell
472,863
-5,948
-1% -$42.8K 0.01% 533
2023
Q1
$2.92M Sell
478,811
-8,199
-2% -$49.9K 0.01% 571
2022
Q4
$2.12M Sell
487,010
-12,641
-3% -$55.1K 0.01% 615
2022
Q3
$1.96M Sell
499,651
-12,650
-2% -$49.6K 0.01% 623
2022
Q2
$2.61M Sell
512,301
-11,677
-2% -$59.6K 0.01% 569
2022
Q1
$3.35M Buy
523,978
+507,190
+3,021% +$3.25M 0.01% 568
2021
Q4
$135K Buy
+16,788
New +$135K ﹤0.01% 1651